Community Research and Development Information Service - CORDIS

Development of a new topic formulation of icrf-187 (dexrazoxane) for treatment of psoriasis

From 1999-11-26 to 2000-05-25

Project details

Total cost:

EUR 30 000

EU contribution:

EUR 22 500

Coordinated in:

Austria

Objective

Coordinator

CSC PHARMACEUTICALS HANDELSGES. MBH
Austria
Heiligenstaederstrasse 395B
1190 WIEN
Austria
See on map
Administrative contact: Jadranka ROGAN-GRGAS

Participants

WINDLESHAW ENTERPRISES LIMITED
United Kingdom
Beech Green Lane Windleshaw House
TN7 4DB Withyham
United Kingdom
See on map
Administrative contact: Kurt HELLMANN
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top